Revolution Medicines, Inc. - Common Stock —— 季度财务数据 (NASDAQ:RVMD) | MetaTrader

展开完整图表完整图表

Financials

概览声明统计

每季度年度

经营活动产生的现金 -138.29 M-194.44 M-221.76 M-207.31 M-274.24 M-354.17 M -1.06 B 投资活动产生的现金 -392.9 M-15.95 M34.28 M24.85 M74.88 M172.62 M 306.62 M 融资活动产生的现金 873.8 M874 K256.58 M-1.59 M365.66 M238.74 M 859.39 M 自由现金流 -138.29 M-194.44 M-229.21 M-210.66 M-276.16 M-355.7 M -1.07 B

新闻

Revolution Medicines' Pancreatic Cancer Pill Doubles Survival, Cuts Death Risk 60% in Trial As Stock Sits

Tango Therapeutics: 'Hold' On Combination Strategy Shift Of Vopimetostat (NASDAQ:TNGX)

Top Research Reports for Home Depot, TJX & Marvell Technology

Erasca: "Hold" On Substantial RAS Targeting ERAS-0015 But With Two Key Risks (NASDAQ:ERAS)

RVMD Reports Wider-Than-Expected Loss in Q1, Raises '26 Expense View

Why This Biotech ETF — The IBD Stock Of The Day — Just Reentered Its Buy Zone

Are These 5 Biotech Stocks Set to Beat Q1 Earnings Estimates?

Why This CEO Is Confident His Drug Can Top 'Unprecedented' Pancreatic Cancer Results

Why Erasca, Up 415% This Year Amid Revolution-Tied Furor, Just Lost Half Its Value

There’s a Revolution in Cancer. But Can Big Pharma Afford It?

Stock Market Hits Highs On Iran Hopes; Goldman Sachs, Netflix, Taiwan Semiconductor In Focus: Weekly Review

Revolution Medicines: "Strong Buy" On Daraxonrasib Win And Expansions Underway (RVMD)